| Announce Date | 10/28/2025 |
| EPS Normalized Actual | $0.509 (Miss by $-0.131) |
| EPS GAAP Actual | $0.509 (Miss by $-0.131) |
| Revenue Actual | $1.288B |
| Revenue Surprise | Beat by $1288M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.57456 |
| EPS GAAP Estimate | $0.57456 |
| Revenue Estimate | $1.389294928B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 3.62 | 8.01 | 3.50556 | 3.74165 | 1 |
| Dec 2027 | 2.88 | 10.07 | 2.81489 | 2.93406 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.51 | -0.06559 | 1.288B | -2.48% | -97.95M |
| FQ2 2025 (Jun 2025) | 0.51 | -0.04337 | 1.305B | -3.52% | -79.27M |
| FQ1 2025 (Mar 2025) | 0.45 | 0.45 | 1.262B | -2.54% | 1262M |
| FQ4 2024 (Dec 2024) | 0.63 | 0.63 | 1.311B | 1.05% | 1311M |
| FQ3 2024 (Sep 2024) | 0.46 | 0.46 | 1.32B | 0.83% | 1320M |
| FQ1 2013 (Mar 2013) | -0.13 | -0.13 | 1.0623B | 100% | 1062.3M |
| FQ2 2013 (Jun 2013) | -0.64 | -0.64 | 1.0623B | 100% | 1062.3M |
| FQ4 2013 (Dec 2013) | -0.25 | -0.25 | 1.1067B | 100% | 1106.7M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.57456
Consensus Revenue Estimates
1.389294928B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.82232 | -- | 0.80636 | 0.84054 | 6 |
| FQ3 2027 (Sep 2027) | 0.89 | -- | 0.86554 | 0.91393 | 4 |
| FQ2 2027 (Jun 2027) | 0.89 | -- | 0.86554 | 0.91393 | 3 |
| FQ1 2027 (Mar 2027) | 0.74482 | -- | 0.72354 | 0.764 | 4 |
| FQ4 2026 (Oct 2026) | 0.64491 | -- | 0.63505 | 0.65423 | 7 |
| FQ3 2026 (Jul 2026) | 0.65483 | 22.12 | 0.64481 | 0.66429 | 4 |
| FQ2 2026 (Jun 2026) | 0.60893 | 16.25 | 0.59212 | 0.63043 | 4 |
| FQ1 2026 (Mar 2026) | 0.51984 | 13.43 | 0.50549 | 0.53819 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.45B | -- | 1.43B | 1.47B | 7 |
| FQ3 2027 (Sep 2027) | 1.46B | -- | 1.43B | 1.49B | 4 |
| FQ2 2027 (Jun 2027) | 1.49B | -- | 1.46B | 1.52B | 6 |
| FQ1 2027 (Mar 2027) | 1.41B | -- | 1.38B | 1.44B | 8 |
| FQ4 2026 (Oct 2026) | 1.44B | -- | 1.42B | 1.46B | 4 |
| FQ3 2026 (Jul 2026) | 1.44B | 10.32 | 1.42B | 1.45B | 4 |
| FQ2 2026 (Jun 2026) | 1.41B | 7.62 | 1.38B | 1.45B | 5 |
| FQ1 2026 (Mar 2026) | 1.38B | 8.78 | 1.35B | 1.42B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.57559 | 0.51 | -0.06559 | -12.86% |
| FQ2 2025 (Jun 2025) | 0.55337 | 0.51 | -0.04337 | -8.5% |
| FQ1 2025 (Mar 2025) | 0.45 | 0.45 | 100% | |
| FQ4 2024 (Dec 2024) | 0.63 | 0.63 | 100% | |
| FQ3 2024 (Sep 2024) | 0.46 | 0.46 | 100% | |
| FQ1 2013 (Mar 2013) | -0.13 | -0.13 | 100% | |
| FQ2 2013 (Jun 2013) | -0.64 | -0.64 | 100% | |
| FQ4 2013 (Dec 2013) | -0.25 | -0.25 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $1.39B | $1.29B | $-97.95M | -7.6% |
| FQ2 2025 (Jun 2025) | $1.38B | $1.31B | $-79.27M | -6.07% |
| FQ1 2025 (Mar 2025) | $0B | $1.26B | $1262M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.31B | $1311M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.32B | $1320M | 100% |
| FQ1 2013 (Mar 2013) | $0B | $1.06B | $1062.3M | 100% |
| FQ2 2013 (Jun 2013) | $0B | $1.06B | $1062.3M | 100% |
| FQ4 2013 (Dec 2013) | $0B | $1.11B | $1106.7M | 100% |